MELISSA GARCIA: Open Payments
NPI 1205801230 · FLOWER MOUND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,881 in 62 payments from 19 companies in 2025. Trend: 2023 $1,782 · 2024 $1,651 · 2025 $1,881
Food & beverage: $1,775Education: $106
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $464 |
| GENZYME CORPORATION | 12 | $342 |
| Regeneron Healthcare Solutions, Inc. | 9 | $278 |
| Novartis Pharmaceuticals Corporation | 7 | $140 |
| Blueprint Medicines Corporation | 1 | $122 |
| SANOFI-AVENTIS U.S. LLC | 2 | $86 |
| Genentech USA, Inc. | 3 | $75 |
| GlaxoSmithKline, LLC. | 3 | $72 |
| CSL Behring | 2 | $45 |
| Amgen Inc. | 1 | $34 |
Products named: DUPIXENT, AIRSUPRA, AYVAKIT, TEZSPIRE, Xolair, TRELEGY ELLIPTA, Rhapsido, ALVESCO.
Industry payments across TX — which companies pay providers there.
